Nuheara: Completes clinical trial

Nuheara Completes clinical trial

  • Nuheara (NUH) completes clinical trial, conducted by the National Acoustics Laboratory (NAL), with all participants data being collected
  • NAL is expected to publish the final clinical trial report by the end of this month
  • The company says this is an important milestone for US FDA 510(K) submission and regulatory clearance
  • The company believes this step will move it closer to entering the US hearing aid market, in line with its expansion plans into global medical devices
  • Managing Director and CEO Justin Miller is pleased with the company’s progress
  • Shares are trading flat today at 1.6 cents each
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

NYSE Parent Invests $600M in Polymarket, Strengthening Market Position

This significant investment signals confidence in the future of predictive markets.Highlights: NYSE's parent company allocates $600M to Polymarket.Investment...

Nexi Expands SEPA Direct Debit with Danish Banks, Enhancing Payments Integration

Nexi's collaboration with Danish banks aims to strengthen payment services across Europe.Highlights: Nexi partners with several Danish banks...

Lloyds Confirms App Glitch Exposed Data of Almost Half a Million Customers

The significant data breach prompts concerns over customer privacy.Highlights: Lloyds Banking Group admits to a data breach affecting...

Mastercard Restricts Sale of Nets Payments Unit Purchased for $3.2 Billion

Mastercard looks to divest its Nets payments segment as part of strategic realignment.Highlights: Mastercard is seeking to sell...